BSC-3201

N/A

Report date: 2023/07/10 17:59:02
NME

Base Information

Drug NameBSC-3201
Drug Alias NameBSC-3201
ClassificationSmall molecules
Mechanisms of ActionNuclear receptor subfamily 4 group A member 2 modulators
TargetsNuclear receptor subfamily 4 group A member 2
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiSiChem Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiSiChem Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A